Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump.
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...
At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...
WASHINGTON — The House’s plan to cut government spending, including on Medicaid, to help pay for the extension of tax cuts is already hitting snags. The House budget resolution, which sets ...
President Trump has selected Sara Carter, a conservative journalist and Fox News contributor, as the nation’s next drug czar.
The apparent choice of a major player in the anti-vaccine community to conduct an HHS study on autism has shocked vaccine ...
Texas’ outbreak began two months ago. State health officials said Friday there were 73 new cases of measles since Tuesday, ...
"The letter canceling my public health project ended with ‘Respectfully,’ of all things. There's nothing respectful about ...
Deputy directors at the FDA center that oversees the regulation of cancer drugs plan to leave, adding to a flood of top ...
The Health and Human Services Department is set to slash 10,000 jobs and streamline authorities under its secretary, Robert F ...
Utah has become the first state to ban fluoride in public drinking water, despite widespread opposition from dentists and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results